We found that the FA translocase, CD36, tended to be increased (p = 0.067, Supplementary Figure 4e), while the solute carrier protein family 27 (SLC27) was decreased (p = 0.029 for SLC27A1, p = 0.0069 for SLC27A2, p = 0.00044 for SLC27A3, p = 0.015 for SLC27A5, Supplementary Figures 4ag, 4ah, 4ad, and 4ak) in the high-risk group, which may suggest that those cancer cells do not rely on the exogenous uptake of FA much. This evidence concerns the gene CD36 and cancer.